Characteristics

Patients

(N = 132)

Purpose of CV-port implantation

p-value

CC group (N = 79)

PC group (N = 53)

Sex, N (%)

Male

90

53 (58.9)

37 (41.1)

Female

42

26 (61.9)

16 (38.1)

0.849

Age (years)

Median (range)

67 (36 - 87)

66 (36 - 85)

67.5 (42 - 87)

0.232

Histology, N (%)

SCLC

35

27 (77.1)

8 (22.9)

NSCLC

97

52 (53.6)

45 (46.4)

0.016

ECOG PS, N (%)

0 - 1

59

58 (98.3)

1 (1.7)

2 - 3

51

20 (39.2)

31 (60.8)

4

22

1 (4.5)

21 (95.5)

<0.0001

Stage, N (%)

I-II

5

4 (80.0)

1 (20.0)

IIIA-B

14

11 (78.6)

3 (21.4)

IV

113

64 (56.6)

49 (43.4)

0.243

Insertion site of the CV-port, N (%)

RSV

91

60 (65.9)

31 (34.1)

LSV

23

13 (56.5)

10 (43.5)

RIV

16

5 (31.3)

11 (68.7)

LIV

1

0 (0.0)

1 (100.0)

RIJV

1

1 (100.0)

0 (0.0)

Preimplantation chemotherapy

Number of regimens, median (range)

2 (0 - 7)

2 (0 - 7)

2 (0 - 6)

0.060

Number of cycles, median (range)

5 (0 - 65)

8 (0 - 65)

4 (0 - 25)

0.006